RENAISSANCE TECHNOLOGIES LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1037389
NEW YORK, NY
Position in XERS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,626,588
-$2,237,743 QoQ
Shares Held
452,860
-26.9% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,198,269,231 across 49 Drug Manufacturers - Specialty & Generic names. XERS ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,787,019 | $1,059,666,526 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,418,897 | $318,665,490 | |
| 3 | ALKS |
Alkermes plc.
|
6,160,428 | $217,832,734 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,859,728 | $108,857,232 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,705,222 | $88,142,925 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,989,100 | $55,358,132 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,469,449 | $48,594,678 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,118,080 | $43,971,340 |
All Filings in XERS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,626,588 | 452,860 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,864,331 | 619,660 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,209,917 | 1,622,840 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,598,437 | 2,055,340 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,872,893 | 2,162,640 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,115,067 | 2,098,840 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,556,352 | 1,598,720 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,041,190 | 1,351,640 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,230,641 | 1,009,340 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,246,854 | 1,381,640 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,900,994 | 1,022,040 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,249,778 | 858,694 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $984,347 | 603,894 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $662,997 | 498,494 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $857,522 | 549,694 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $991,288 | 643,694 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,774,064 | 692,994 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,578,968 | 880,194 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||